1970
DOI: 10.1136/adc.45.239.93
|View full text |Cite
|
Sign up to set email alerts
|

Controlled Trial of Phenobarbitone in Neonatal Jaundice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
9
1
2

Year Published

1971
1971
1991
1991

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 13 publications
0
9
1
2
Order By: Relevance
“…Phenobarbitone therapy started after the appearance of jaundice seemed to be far less effective, though some studies (Yeung and Field, 1969;Stern et al, 1970;Sinniah, Tay, and Dugdale, 1971) have shown reduced need for exchange transfusions and lower plasma bilirubin levels, while others (Levin, McMullin, and Mobarak, 1970;Cunningham, Mace, and Peters, 1969) have found no significant difference.…”
mentioning
confidence: 99%
“…Phenobarbitone therapy started after the appearance of jaundice seemed to be far less effective, though some studies (Yeung and Field, 1969;Stern et al, 1970;Sinniah, Tay, and Dugdale, 1971) have shown reduced need for exchange transfusions and lower plasma bilirubin levels, while others (Levin, McMullin, and Mobarak, 1970;Cunningham, Mace, and Peters, 1969) have found no significant difference.…”
mentioning
confidence: 99%
“…Our findings may contribute to explaining the failure of phenobarbitone action observed by some investigators if administration of phenobarbitone started in babies who already manifested definite jaundice [4,8]. We assume that maturation of the bilirubin excretory mechanism proceeds very quickly in term infants ( fig.…”
Section: Discussionmentioning
confidence: 78%
“…However, reports have appeared which cast doubt on this property of phenobarbitone [4,8]. The exact means by which phenobarbitone acts on bilirubin meta bolism in man still remains obscure [16].…”
mentioning
confidence: 99%
“…A recent controlled trial (Levin, McMullin, and Mobarak, 1970) of phenobarbitone in the treatment of neonatal jaundice revealed a small but significant reduction of the mean bilirubin level of treated cases 24 hours after starting treatment. But as there were no significant differences in the mean bilirubin levels of the treated and untreated cases at 48 and 72 hours after starting treatment, and as there was no significant difference in the maximum recorded levels between the 2 groups, it was concluded by the authors that phenobarbitone had no place in the management of established neonatal jaundice.…”
Section: Discussionmentioning
confidence: 99%